Peter Bisgaard is a managing director at Pivotal Life Sciences and a managing partner at Pivotal bioVenture Partners. He previously held senior roles at Novo Ventures and worked at McKinsey & Co.
At firms with a similar stage, sector and check size.
One email when Peter's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckPeter Bisgaard is a managing director at Pivotal Life Sciences and a managing partner at Pivotal bioVenture Partners. He previously held senior roles at Novo Ventures and worked at McKinsey & Co.
Peter Bisgaard invests through Pivotal bioVenture Partners, which writes checks of $3M to $30M at pre-seed, seed, series a, series b.
A warm intro from a founder Pivotal bioVenture Partners backed works best.
McKinsey & Co.; Novo Ventures; Senior Partner at Novo Holdings/ Novo Ventures (US) Inc.; Managing Director at Pivotal Life Sciences.
Last updated 2026-10-15. Is this you? Ask for a correction.